Bone marrow was cultured in vitro for colonies of granulocytes and macrophages five months after a patient had recovered from amodiaquine induced agranulocytosis. The addition of amodiaquine, chloroquine, and sulfadoxine to the culture was followed by a dose dependent inhibition of colony growth in the patient's marrow but not in normal control bone marrow. Colony growth was, however, unaffected by proguanil, pyrimethamine, and quinine.
Introduction
Amodiaquine has been associated with agranulocytosis in a few patients taking both therapeutic and prophylactic doses of the drug.' A patient with amodiaquine related agranulocytosis was investigated five months after recovery to determine the in vitro sensitivity of colony formation in her bone marrow 
Results
The patient's and control bone marrow samples grew normally in the absence of antimalarial drugs. No antimalarial had any effect on normal marrow growth. Proguanil, pyrimethamine, and quinine had no effect on growth of the patient's marrow. Amodiaquine, chloroquine (a related 4-aminoquinoline), and sulfadoxine, however, produced a dose dependent reduction in the number of colonies (figure).
Discussion
These results suggest that amodiaquine was responsible for the agranulocytosis since growth of colonies of granulocytes and macrophages was sensitive to this agent and recovery ensued on stopping the amodiaquine alone. Another patient with agranulocytosis had shown in vitro inhibition of growth of granulocytes and macrophages by amodiaquine early in the recovery phase.' A similar in vitro inhibitory effect was seen in a case of agranulocytosis induced by quinine.3 A specific effect on marrow colony growth is suggested,.separate from any systemic abnormality ofdrug handling.
Our patient wished to know if she could take any medication to enable her to travel safely to areas where malaria was endemic. Clearly, amodiaquine, chloroquine, and sulfadoxine were to be avoided. Twhough we could not be certain that the other drugs tested would be safe, our results suggested that in vitro marrow culture may have important predictive value in some cases of drug induced ulocytosis.
Introduction
Cytomegalovirus is the most common known cause of congenital infection in man and is as important, or more important, than rubella as a cause of handicap. In the United Kingdom 40-50% of women of childbearing age are seronegative and rather fewer than 1% of these undergo pnrmary infection at some time during pregnancy.,- the fetus occurs in 25-50% of cases.'4 Only 10-14% of the infected fetuses, however, suffer important sequelae, usually neurological damage or sensorineural deafness.5-7 The overall risk ofa baby being born with congenital abnormality after primary infection in the mother is therefore relatively low, probably 5% or less. Hence it has been advocated that, as there is no means of identifying the pregnancies most at risk ofresulting in a handicapped baby, neither screening for primary infection nor termination, as offered for rubella, is justified.89
Women,who have given birth to babies congenitally infected with cytomegalovirus have been found to have depressed cell mediated immunity to cytomegalovirus, demonstrable by the lymphocyte transformation test,'0 1 with a tendency to greater depression in the mothers who had given birth to infants with abnormalities.'2 All these studies, however, were carried out only after delivery, usually many months later. This study was undertaken to see whether measurement of lymphocyte transformation response during pregnancy, at the time ofoccurrence ofthe primary infection, could predict the likelihood of intrauterine infection. Such information would be invaluable in clinical management.
Patients and methods
Since July 1982 women attending the antenatal booking clinics of St George's-Hospital and the South London Hospital have been routinely screened for serum cytomegalovirus specific IgG by indirect enzyme linked immunosorbent assay.'3 Positive serum samples were re-exaniined for cytomegalovirus specific IgM, also by indirect enzyme linked immunosorbent assay, to determine whether infection had occurred within the preceding two to three months (see below). Most of the women were first seen at about 12 weeks' gestation. Women who were seronegative were reamined at intervals during the pregnancy for seroconversion. When primary infection was diagnosed, whether by seroconversion or by the presence ofcytomegalovirus specific IgM, the patient was recalled as soon as possible and a lymphocyte transformation test carried"out; this was repeated at further intervals during pregnancy and again at term. All women enrolled in the investigation were made fully aware of its nature, and follow up examinations were undertaken only with their consent; about a third of the
